| Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas M Losa, F Bogazzi, S Cannavo, F Ceccato, L Curtò, L De Marinis, ... Journal of Neuro-Oncology 126, 519-525, 2016 | 128 | 2016 |
| Salivary cortisol and cortisone by LC–MS/MS: validation, reference intervals and diagnostic accuracy in Cushing's syndrome G Antonelli, F Ceccato, C Artusi, M Marinova, M Plebani Clinica chimica acta 451, 247-251, 2015 | 104 | 2015 |
| Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? M Barbot, N Albiger, F Ceccato, M Zilio, AC Frigo, L Denaro, F Mantero, ... Pituitary 17, 109-117, 2014 | 97 | 2014 |
| An analysis of different therapeutic options in patients with C ushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single‐centre experience NM Albiger, F Ceccato, M Zilio, M Barbot, G Occhi, S Rizzati, A Fassina, ... Clinical endocrinology 82 (6), 808-815, 2015 | 85 | 2015 |
| Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency F Ceccato, M Barbot, M Zilio, S Ferasin, G Occhi, A Daniele, S Mazzocut, ... European Journal of Endocrinology 169 (1), 31-36, 2013 | 85 | 2013 |
| Screening tests for Cushing's syndrome: urinary free cortisol role measured by LC-MS/MS F Ceccato, M Barbot, M Zilio, AC Frigo, N Albiger, V Camozzi, G Antonelli, ... The Journal of Clinical Endocrinology & Metabolism 100 (10), 3856-3861, 2015 | 77 | 2015 |
| Cushing’s syndrome: screening and diagnosis F Ceccato, M Boscaro High Blood Pressure & Cardiovascular Prevention 23, 209-215, 2016 | 76 | 2016 |
| Diagnosis and complications of Cushing's disease: gender‐related differences M Zilio, M Barbot, F Ceccato, V Camozzi, F Bilora, A Casonato, AC Frigo, ... Clinical endocrinology 80 (3), 403-410, 2014 | 75 | 2014 |
| The pathophysiology and treatment of hypertension in patients with Cushing's syndrome M Barbot, F Ceccato, C Scaroni Frontiers in endocrinology 10, 321, 2019 | 69 | 2019 |
| A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical … NM Albiger, D Regazzo, B Rubin, AM Ferrara, S Rizzati, E Taschin, ... Endocrine 55, 959-968, 2017 | 69 | 2017 |
| Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature R Manara, P Maffei, V Citton, S Rizzati, G Bommarito, M Ermani, I Albano, ... The Journal of Clinical Endocrinology & Metabolism 96 (5), 1292-1300, 2011 | 69 | 2011 |
| Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study T Deutschbein, G Reimondo, G Di Dalmazi, I Bancos, J Patrova, ... The Lancet Diabetes & Endocrinology 10 (7), 499-508, 2022 | 67 | 2022 |
| Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple … G Occhi, G Trivellin, F Ceccato, P De Lazzari, G Giorgi, S Dematte, ... European Journal of Endocrinology 163 (3), 369-376, 2010 | 64 | 2010 |
| Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome M Barbot, L Trementino, M Zilio, F Ceccato, N Albiger, A Daniele, ... Pituitary 19, 488-495, 2016 | 63 | 2016 |
| Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center F Ceccato, G Lombardi, R Manara, E Emanuelli, L Denaro, L Milanese, ... Journal of Neuro-Oncology 122, 189-196, 2015 | 62 | 2015 |
| Diabetes mellitus secondary to Cushing’s disease M Barbot, F Ceccato, C Scaroni Frontiers in endocrinology 9, 284, 2018 | 61 | 2018 |
| Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations ML Jaffrain-Rea, S Rotondi, A Turchi, G Occhi, A Barlier, E Peverelli, ... Endocrine-Related Cancer 20 (5), 753-766, 2013 | 61 | 2013 |
| The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: mutational hot-spot or founder effect? G Occhi, ML Jaffrain-Rea, G Trivellin, N Albiger, F Ceccato, E De Menis, ... Journal of Endocrinological Investigation 33, 800-805, 2010 | 56 | 2010 |
| Perioperative thromboprophylaxis in Cushing’s disease: what we did and what we are doing? M Barbot, V Daidone, M Zilio, N Albiger, L Mazzai, MT Sartori, AC Frigo, ... Pituitary 18, 487-493, 2015 | 55 | 2015 |
| Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab M Caccese, M Barbot, F Ceccato, M Padovan, MP Gardiman, M Fassan, ... Anti-Cancer Drugs 31 (2), 199-204, 2020 | 51 | 2020 |
